ANTHEM vs FABTECH: Stock Comparison
ANTHEM BIOSCIENCES is the larger company by market capitalisation. ANTHEM BIOSCIENCES shows a higher ROE, faster revenue growth and lower leverage, while FABTECH TECHNOLOGIES shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ANTHEM leads 9; FABTECH leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ANTHEM | FABTECH |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Equipment & Supplies |
Price
| Metric | ANTHEM | FABTECH |
|---|---|---|
| Live Price | ₹917.55 | ₹147.34 |
| Day Change | 1% | 1.15% |
| Volume | 1.73 L | 30,582 |
| 52-Week High | ₹977.55 | ₹262.8 |
| 52-Week Low | ₹579.15 | ₹132.7 |
| Distance from 52W High | -6.14% | -43.93% |
Valuation
| Metric | ANTHEM | FABTECH |
|---|---|---|
| Market Cap | ₹51,941 Cr | ₹654 Cr |
| P/E Ratio | 89.17x | 13.38x |
| P/B Ratio | 16.88x | 1.55x |
| EPS | ₹10.09 | ₹10.96 |
| Book Value | ₹54.17 | ₹109.44 |
| Dividend Yield | 0.21% | 0.41% |
Growth
| Metric | ANTHEM | FABTECH |
|---|---|---|
| Revenue Growth (TTM YoY) | 26.4% | 17.5% |
| EPS Growth (TTM YoY) | 127.2% | 23.4% |
| Qtr Sales Growth | -8.22% | -34.46% |
| Qtr Profit Growth | -14.95% | -74.83% |
Profitability & Leverage
| Metric | ANTHEM | FABTECH |
|---|---|---|
| ROE | 21.06% | 6.22% |
| ROCE | 22.79% | 6.94% |
| Net Margin | 26.05% | 11.28% |
| Operating Margin | 43.54% | 13.72% |
| Debt to Equity | 0.01x | 0.05x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ANTHEM | FABTECH |
|---|---|---|
| Promoter Holding | 71.42%▼ 3.26 pp | 68.94% |
| FII Holding | 2.58%▲ 1.3 pp | 0.02%▼ 0.06 pp |
| DII Holding | 13.48%▲ 1.93 pp | 2.45%▲ 0.3 pp |
| Public Holding | 12.53%▲ 0.03 pp | 28.58%▼ 0.25 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ANTHEM BIOSCIENCES and FABTECH TECHNOLOGIES.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.